{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:39:38Z","timestamp":1791243578361,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004113","name":"Universit\u00e9 Libanaise","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004113","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004562","name":"Minist\u00e8re de l&apos;Education Nationale, de l&apos;Enseignement Superieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.yexcr.2016.05.023","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T12:35:51Z","timestamp":1464784551000},"page":"60-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Resistance to ursolic acid-induced apoptosis through involvement of melanogenesis and COX-2\/PGE2 pathways in human M4Beu melanoma cancer cells"],"prefix":"10.1016","volume":"345","author":[{"given":"Lama","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Pinon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youness","family":"Limami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Seeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Fidanzi-Dugas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederique","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam","family":"Badran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Liagre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2016.05.023_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.soncn.2013.06.002","article-title":"Skin cancer: an overview of epidemiology and risk factors","volume":"29","author":"Gordon","year":"2013","journal-title":"Semin. Oncol. Nurs."},{"key":"10.1016\/j.yexcr.2016.05.023_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.mrrev.2010.06.002","article-title":"Genetics of pigmentation in skin cancer\u2014a review","volume":"705","author":"Scherer","year":"2010","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib3","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1096\/fasebj.5.14.1752358","article-title":"Enzymatic control of pigmentation in mammals","volume":"5","author":"Hearing","year":"1991","journal-title":"FASEB J."},{"key":"10.1016\/j.yexcr.2016.05.023_bib4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","volume":"84","author":"Slominski","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yexcr.2016.05.023_bib5","first-page":"31","article-title":"Epidemiology, risk factor and screening for melanoma and other skin cancers","volume":"64","author":"Lanoy","year":"2014","journal-title":"Rev. Prat."},{"key":"10.1016\/j.yexcr.2016.05.023_bib6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mrfmmm.2004.11.016","article-title":"Melanogenesis: a photoprotective response to DNA damage?","volume":"571","author":"Agar","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib7","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/ijc.23664","article-title":"Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy","volume":"123","author":"Brozyna","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2016.05.023_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1515\/hsz-2012-0228","article-title":"Melanoma resistance to photodynamic therapy: new insights","volume":"394","author":"Huang","year":"2013","journal-title":"Biol. Chem."},{"key":"10.1016\/j.yexcr.2016.05.023_bib9","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1038\/sj.onc.1206454","article-title":"Apoptosis and melanoma chemoresistance","volume":"22","author":"Soengas","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2016.05.023_bib10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1755-148X.2009.00630.x","article-title":"Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma","volume":"22","author":"Chen","year":"2009","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib11","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1038\/sj.onc.1206456","article-title":"Death receptors and melanoma resistance to apoptosis","volume":"22","author":"Ivanov","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2016.05.023_bib12","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.yexcr.2011.04.014","article-title":"A novel form of melanoma apoptosis resistance: melanogenesis up-regulation in apoptotic B16-F0 cells delays ursolic acid-triggered cell death","volume":"317","author":"Pinon","year":"2011","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib13","first-page":"6323","article-title":"Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells","volume":"62","author":"Sun","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib14","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.1158\/0008-5472.CAN-05-3624","article-title":"Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis","volume":"66","author":"Xu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","article-title":"Prostaglandins and cancer","volume":"55","author":"Wang","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.yexcr.2016.05.023_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","article-title":"The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment","volume":"30","author":"Greenhough","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yexcr.2016.05.023_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.biochi.2011.01.003","article-title":"HT-29 colorectal cancer cells undergoing apoptosis overexpress COX-2 to delay ursolic acid-induced cell death","volume":"93","author":"Limami","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.yexcr.2016.05.023_bib18","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.biochi.2012.04.006","article-title":"The P2Y2\/Src\/p38\/COX-2 pathway is involved in the resistance to ursolic acid-induced apoptosis in colorectal and prostate cancer cells","volume":"94","author":"Limami","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.yexcr.2016.05.023_bib19","first-page":"303","article-title":"Expression of cyclooxygenase 2 in human malignant melanoma","volume":"61","author":"Denkert","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.cmr.0000194430.77643.a0","article-title":"Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression","volume":"16","author":"Kuzbicki","year":"2006","journal-title":"Melanoma Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/CMR.0b013e32831d7f52","article-title":"COX-2 expression in malignant melanoma: a novel prognostic marker?","volume":"19","author":"Becker","year":"2009","journal-title":"Melanoma Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF00205410","article-title":"Tumour-associated antigens in culture medium of malignant melanoma cell strains","volume":"7","author":"Jacubovich","year":"1979","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.yexcr.2016.05.023_bib23","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s10495-006-9439-7","article-title":"Low dose leflunomide activates PI3K\/Akt signalling in erythroleukemia cells and reduces apoptosis induced by anticancer agents","volume":"11","author":"Leger","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.yexcr.2016.05.023_bib24","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s10495-013-0825-7","article-title":"Cyclooxygenase-2 positively regulates Akt signalling and enhances survival of erythroleukemia cells exposed to anticancer agents","volume":"18","author":"Bertrand","year":"2013","journal-title":"Apoptosis"},{"key":"10.1016\/j.yexcr.2016.05.023_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.20588","article-title":"Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells","volume":"114","author":"Harmand","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2016.05.023_bib26","first-page":"145","article-title":"Differential involvement of mitochondria during ursolic acid-induced apoptotic process in HaCaT and M4Beu cells","volume":"19","author":"Duval","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2016.05.023_bib27","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.yexcr.2012.03.022","article-title":"Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance","volume":"318","author":"Saez-Ayala","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.gt.3302868","article-title":"Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf","volume":"14","author":"Nakai","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.yexcr.2016.05.023_bib29","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1042\/CBI20110103","article-title":"Photodynamic therapy-induced killing is enhanced in depigmented metastatic melanoma cells","volume":"35","author":"Sharma","year":"2011","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.yexcr.2016.05.023_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/CMR.0b013e3280dec6ac","article-title":"Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours","volume":"17","author":"Chwirot","year":"2007","journal-title":"Melanoma Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fonc.2014.00383","article-title":"Evaluating biomarkers in melanoma","volume":"4","author":"Karagiannis","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2016.05.023_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1751-1097.2007.00261.x","article-title":"Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis","volume":"84","author":"Rundhaug","year":"2008","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.yexcr.2016.05.023_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1582-4934.2003.tb00222.x","article-title":"Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis","volume":"7","author":"Trifan","year":"2003","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.yexcr.2016.05.023_bib34","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.yexcr.2013.01.014","article-title":"Cyclopamine and jervine induce COX-2 overexpression in human erythroleukemia cells but only cyclopamine has a pro-apoptotic effect","volume":"319","author":"Ghezali","year":"2013","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib35","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.jid.5700191","article-title":"Cyclooxygenase-2 overexpression in human basal cell carcinoma cell line increases antiapoptosis, angiogenesis, and tumorigenesis","volume":"126","author":"Tjiu","year":"2006","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.yexcr.2016.05.023_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archderm.1986.01660160063020","article-title":"Arachidonic acid metabolites in cutaneous carcinomas. Evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern","volume":"122","author":"Vanderveen","year":"1986","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.yexcr.2016.05.023_bib37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/carcin\/bgq215","article-title":"Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E(2) and prostaglandin E(2) receptors","volume":"32","author":"Singh","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yexcr.2016.05.023_bib38","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1158\/0008-5472.CAN-06-3617","article-title":"Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4","volume":"67","author":"Chun","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1755-148X.2010.00696.x","article-title":"Prostaglandin-E2 is produced by adult human epidermal melanocytes in response to UVB in a melanogenesis-independent manner","volume":"23","author":"Gledhill","year":"2010","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.yexcr.2016.05.023_bib40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0625.2012.01483.x","article-title":"siRNA-mediated knock-down of COX-2 in melanocytes suppresses melanogenesis","volume":"21","author":"Kim","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.yexcr.2016.05.023_bib41","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/exd.12669","article-title":"The antimycotic agent clotrimazole inhibits melanogenesis by accelerating ERK and PI3K-\/Akt-mediated tyrosinase degradation","volume":"24","author":"Chung","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.yexcr.2016.05.023_bib42","doi-asserted-by":"crossref","first-page":"14334","DOI":"10.3390\/molecules200814334","article-title":"Mimosine dipeptide enantiomsers: improved inhibitors against melanogenesis and cyclooxygenase","volume":"20","author":"Nguyen","year":"2015","journal-title":"Molecules"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482716301410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482716301410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T02:21:50Z","timestamp":1655950910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482716301410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0014482716301410"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2016.05.023","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance to ursolic acid-induced apoptosis through involvement of melanogenesis and COX-2\/PGE2 pathways in human M4Beu melanoma cancer cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2016.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}